CellType

CellType

The agentic drug company. We simulate human biology.

New York City, NY
5 employees
Drug Discovery and Delivery
Pre-seed · $500K

About CellType

The agentic drug company. We simulate human biology.

Open positions (1)

Company details

Team Size5
LocationNew York City, NY
IndustryDrug Discovery and Delivery

Funding

Total raised

$500K

Last stage

Pre-seed

Investors

Y Combinator
Pioneer Fund

Founders

David van Dijk

David van Dijk

Co-Founder & CEO of CellType (W26). Yale Professor, 11,000+ citations. Built biological foundation models with Google. Building the agentic drug company.

LinkedIn
Ivan Vrkic

Ivan Vrkic

Co-Founder @ CellType (W26). ML @ Yale & EPFL. Building the next-generation agentic drug company. Co-developed our core technology Cell2Sentence at Yale and published at ICML. Previously led large-scale foundation model training at a biotech startup and built software to control CERN's Large Hadron Collider.

LinkedIn

What happens next.

No applications, no recruiter spam. Just the intro.

01

Confirm the fit

A few questions to make sure this role is the right shape for you. Two minutes.

02

I pitch you to the company

I write the intro, send it to the founder, and handle the back-and-forth.

03

A meeting lands on your calendar

If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.